The ANAPC4 siRNA and ANAPC4+/+ groups presented larger and smaller mean tumor masses, respectively, than the control group (Figure 6D).Figure 6E showed the inhibitory effects of ANAPC4 on PTC progressionin vivo. The gene discussed is ANAPC4; the disease is neoplasm.